AAAAAA

   
Results: 1-12 |
Results: 12
MHC CLASS II-INDEPENDENT, V-BETA-SPECIFIC ACTIVATION OF T-CELLS BY SUPERANTIGEN MUTANTS FUSED TO ANTITUMOR F-AB FRAGMENTS - IMPLICATIONS FOR USE IN TREATMENT OF HUMAN COLON-CARCINOMA
Authors: NEWTON DW DOHLSTEN M LANDO PA KALLAND T OLSSON C KOTB M
Citation: Dw. Newton et al., MHC CLASS II-INDEPENDENT, V-BETA-SPECIFIC ACTIVATION OF T-CELLS BY SUPERANTIGEN MUTANTS FUSED TO ANTITUMOR F-AB FRAGMENTS - IMPLICATIONS FOR USE IN TREATMENT OF HUMAN COLON-CARCINOMA, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(1), 1998, pp. 157-162
BIASED DEPENDENCY OF CD80 VERSUS CD86 IN THE INDUCTION OF TRANSCRIPTION FACTORS REGULATING THE HUMAN IL-2 PROMOTER
Authors: OLSSON C MICHAELSSON E PARRA E PETTERSSON U LANDO PA DOHLSTEN M
Citation: C. Olsson et al., BIASED DEPENDENCY OF CD80 VERSUS CD86 IN THE INDUCTION OF TRANSCRIPTION FACTORS REGULATING THE HUMAN IL-2 PROMOTER, International immunology, 10(4), 1998, pp. 499-506
GENETICALLY-ENGINEERED SUPERANTIGENS IN EXPERIMENTAL TUMOR-THERAPY
Authors: ANTONSSON P HANSSON J KALLAND T LANDO PA OHLSSON L SCHAD E SVENSSON A DOHLSTEN M
Citation: P. Antonsson et al., GENETICALLY-ENGINEERED SUPERANTIGENS IN EXPERIMENTAL TUMOR-THERAPY, Perspectives in mathematical logic, 17(4), 1996, pp. 397-410
MUTATIONS IN THE MHC CLASS-II BINDING DOMAINS OF STAPHYLOCOCCAL-ENTEROTOXIN-A DIFFERENTIALLY AFFECT T-CELL RECEPTOR V-BETA SPECIFICITY
Authors: NEWTON DW DOHLSTEN M OLSSON C SEGREN S LUNDIN KEA LANDO PA KALLAND T KOTB M
Citation: Dw. Newton et al., MUTATIONS IN THE MHC CLASS-II BINDING DOMAINS OF STAPHYLOCOCCAL-ENTEROTOXIN-A DIFFERENTIALLY AFFECT T-CELL RECEPTOR V-BETA SPECIFICITY, The Journal of immunology, 157(9), 1996, pp. 3988-3994
REGULATION OF SUPERANTIGEN-INDUCED T-CELL ACTIVATION IN THE ABSENCE AND THE PRESENCE OF MHC CLASS-II
Authors: LANDO PA OLSSON C KALLAND T NEWTON D KOTB M DOHLSTEN M
Citation: Pa. Lando et al., REGULATION OF SUPERANTIGEN-INDUCED T-CELL ACTIVATION IN THE ABSENCE AND THE PRESENCE OF MHC CLASS-II, The Journal of immunology, 157(7), 1996, pp. 2857-2863
ANTIBODY-TARGETED SUPERANTIGEN THERAPY INDUCES TUMOR-INFILTRATING LYMPHOCYTES, EXCESSIVE CYTOKINE PRODUCTION, AND APOPTOSIS IN HUMAN COLON-CARCINOMA
Authors: LITTON MJ DOHLSTEN M LANDO PA KALLAND T OHLSSON L ANDERSSON J ANDERSSON U
Citation: Mj. Litton et al., ANTIBODY-TARGETED SUPERANTIGEN THERAPY INDUCES TUMOR-INFILTRATING LYMPHOCYTES, EXCESSIVE CYTOKINE PRODUCTION, AND APOPTOSIS IN HUMAN COLON-CARCINOMA, European Journal of Immunology, 26(1), 1996, pp. 1-9
IMMUNOTHERAPY OF HUMAN COLON-CANCER BY ANTIBODY-TARGETED SUPERANTIGENS
Authors: DOHLSTEN M LANDO PA ABRAHMSEN PBL OHLSSON L KALLAND PLT
Citation: M. Dohlsten et al., IMMUNOTHERAPY OF HUMAN COLON-CANCER BY ANTIBODY-TARGETED SUPERANTIGENS, Cancer immunology and immunotherapy, 41(3), 1995, pp. 162-168
TUMOR-REACTIVE SUPERANTIGENS SUPPRESS TUMOR-GROWTH IN HUMANIZED SCID MICE
Authors: LANDO PA DOHLSTEN M OHLSSON L KALLAND T
Citation: Pa. Lando et al., TUMOR-REACTIVE SUPERANTIGENS SUPPRESS TUMOR-GROWTH IN HUMANIZED SCID MICE, International journal of cancer, 62(4), 1995, pp. 466-471
MONOCLONAL ANTIBODY-SUPERANTIGEN FUSION PROTEINS - TUMOR-SPECIFIC AGENTS FOR T-CELL-BASED TUMOR-THERAPY
Authors: DOHLSTEN M ABRAHMSEN L BJORK P LANDO PA HEDLUND G FORSBERG G BRODIN T GASCOIGNE NRJ FORBERG C LIND P KALLAND T
Citation: M. Dohlsten et al., MONOCLONAL ANTIBODY-SUPERANTIGEN FUSION PROTEINS - TUMOR-SPECIFIC AGENTS FOR T-CELL-BASED TUMOR-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(19), 1994, pp. 8945-8949
MONOCLONAL-ANTIBODIES AND SUPERANTIGENS - A NOVEL THERAPEUTIC APPROACH
Authors: KALLAND T DOHLSTEN M LIND P SUNDSTEDT A ABRAHMSEN L HEDLUND G BJORK P LANDO PA BJORKLUND M
Citation: T. Kalland et al., MONOCLONAL-ANTIBODIES AND SUPERANTIGENS - A NOVEL THERAPEUTIC APPROACH, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 37-47
CD28 B7 COSTIMULATION IN T-CELL ACTIVATION AND TUMOR-CYTOTOXICITY BY SUPERANTIGEN-MAB CONJUGATES/
Authors: LANDO PA DOHLSTEN M HEDLUND G BRODIN T KALLAND T
Citation: Pa. Lando et al., CD28 B7 COSTIMULATION IN T-CELL ACTIVATION AND TUMOR-CYTOTOXICITY BY SUPERANTIGEN-MAB CONJUGATES/, The Journal of immunology, 150(8), 1993, pp. 114-114
CO-STIMULATION WITH B7 AND TARGETED SUPERANTIGEN IS REQUIRED FOR MHC CLASS II-INDEPENDENT T-CELL PROLIFERATION BUT NOT CYTOTOXICITY
Authors: LANDO PA DOHLSTEN M HEDLUND G BRODIN T SANSOM D KALLAND T
Citation: Pa. Lando et al., CO-STIMULATION WITH B7 AND TARGETED SUPERANTIGEN IS REQUIRED FOR MHC CLASS II-INDEPENDENT T-CELL PROLIFERATION BUT NOT CYTOTOXICITY, Immunology, 80(2), 1993, pp. 236-241
Risultati: 1-12 |